Clinical Trial Update: ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ZD4054 (Zibotentan) in pain-free or mildly symptomatic patients with prostate cancer and bone metastases who have rising PSA; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ZD4054 (Zibotentan) (zibotentan)

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-09-03